Southeast Life Sciences Announces Award Winners and PitchRounds Winners for the first AdvanSE Life Sciences Conference

Southeast Life Sciences Announces Award Winners and PitchRounds Winners for the first AdvanSE Life Sciences Conference.

November 13, 2020

On the closing day of the first annual Southeast Life Sciences conference, the AdvanSE Life Sciences Conference, we want to congratulation the winners of our awards and PitchRounds.

Southeast Life Sciences awards include awards for best initial funding, best venture funding, best strategic partnership, best M&A, and best IPO. The winners of these are as follows. These awards go back more than a decade from both Southeast BIO and the Southeast Medical Device Association prior to the merger. Some of the biggest success stories from the southeast have been included in these awards and we expect the same big things with our winners this year!

  • For best Initial Funding (seed or angel), the winner is Acclinate Genetics, from Huntsville, Alabama.
  • For best Venture Funding (>$1mm from institutional investors), the winner is Embody Inc., from Norfolk, VA
  • For best Strategic Partnership, the winner is SiO2, of Auburn, Alabama
  • For best M&A, the award goes to AskBio, from RTP, NC, which was acquired by Bayer AG.
  • For best IPO, the award goes to Shattuck Labs, from Durham, NC and Austin, TX

SE PitchRounds this year took in more than 70 applications from across the region for only 22 slots. These 20 companies represented the most exciting technologies and some of the most experienced entrepreneurs in the region. From the initial 22, we selected four finalists that presented on the closing day of the conference. The finalists were Embody, Inc., Moterum, HeamGen, and Stuart Therapeutics.

The winners from the bipharma/diagnostic group was Stuart Therapeutics.

The winner from  the medtech/digital group was Embody, Inc.

Congratulations to Everyone!

Southeast Life Sciences Launches SE Color

Southeast Life Sciences Launches SE Color
SE Color will initiate “We Are In” Campaign to encourage minorities to participate in Clinical Trials.

On September 9, Southeast Life Sciences announced the formation of SE Color, an organization dedicated to support minority life science entrepreneurship, increase investment in minority-owned life science businesses, and improve minority access to information and clinical opportunities.

The founding advisory board members are Jayne Morgan MD, Clinical Director, Covid Task Force at Piedmont Healthcare, Kornelius Bankston, Managing Partner with techPLUG, and John Newby, Chief Executive Officer for Virginia BIO. As executive director of Southeast Life Sciences, Jason Rupp will staff the organization.

SE Color’s initial effort will focus on increasing the number of minorities in clinical trials. In an article published in Healthcare Tech Outlook, Dr. Morgan notes that, “African Americans make up 13.4 percent of the US population, yet only 5 – 7 percent of clinical trial participants nationally.”

Dr. Morgan further states, “Nearly every advance in medicine today was first evaluated in a clinical trial. Clinical trials offer our best and most forward thinking and can be the gateway to provide earlier access to life saving medicines and therapies years ahead of FDA approval. Equitable participation in clinical trials is therefore a critical call to action in ensuring that medicines, devices, and vaccines that are developed are relevant to all populations.”

Although there are many aspects to facilitate minority recruitment in clinical trials, SE Color will initially focus on education through the “We Are In” campaign. The initial priority will be to share information on clinical trials available throughout the southeast. SE Color will partner with state associations in the region to ensure we have updated information and extend the network.

Southeast Life Sciences recognizes the great need for effort in these areas and though we will only be one part of the solution, we will be part of it. In closing, Bankston adds “I believe the greatest social injustice in modern history is health inequalities which disproportionately impact people of color. We can create more effective therapeutics, applications and medicines for all populations- by addressing the systemic issues in clinical research.”

Dr. Michelle McMurry-Heath Headlines Medtech Women Conference

We are very excited to announce that our Keynote Speaker this year will be Dr. Michelle McMurry-Heath, President & CEO of the Biotechnology Innovation Organization, who took over the CEO position at BIO in June, replacing Jim Greenwood. I’ve spoken to many of my former colleauges at BIO, who say she is a dynamic leader who’s hit the ground running. BIO recently annouced a new diversity & inclusion program, The Right Mix Matters, so we’re thrilled that she will close our event this year!

 

Dr. Michelle McMurry-Heath

President & CEO
Biotechnology Innovation Organization

Michelle McMurry-Heath assumed the leadership of the Biotechnology Innovation Organization (BIO) as President and CEO on June 1, 2020. A medical doctor and molecular immunologist by training, Dr. McMurry-Heath becomes just the third chief executive to steward the world’s largest biotechnology advocacy group since BIO’s founding in 1993.

The common thread in McMurry-Heath’s work across academia, government and industry has been her focus on broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation. Driven by her own past family experiences navigating clinical trials and funding uncertainties within the rare disease community, McMurry-Heath calls “the distribution of scientific progress the social justice issue of our age.”

She comes to BIO from Johnson & Johnson where she served as Global Head of Evidence Generation for Medical Device Companies and then Vice President of Global External Innovation and Global Leader for Regulatory Sciences. She was also instrumental in bringing J&J’s incubator, JLabs, to Washington, DC. She led a global team of 900 with responsibilities in 150 countries around the globe.

Prior to her time at J&J, Dr. McMurry-Heath was also a key science policy leader in government. The Obama-Biden transition team tapped her to conduct a comprehensive analysis of the National Science Foundation’s policies, programs and personnel. President Obama then named her associate science director of the FDA’s Center for Devices and Radiological Health under Commissioner Peggy Hamburg. In that role, she championed clinical trial evolution, the use of real-world evidence in product evaluation, and an embrace of the patient’s voice in health research so new medical products deliver outcomes that matter to them.

McMurry-Heath was the founding director of the Aspen Institute’s Health, Biomedical Science, and Society Policy Program, where she promoted personalized medicine and bolstered international preparation for pandemic disease threats. She received her early training in science policy from the Robert Wood Johnson Foundation and later served as Senator Joe Lieberman’s top legislative aide for science and health. In that role, she drafted legislation to protect the country from biological attacks.

McMurry-Heath received her MD/PhD from Duke’s Medical Scientist Training Program, becoming the first African-American to graduate from the

August 5 Covid-19 Update

Most of the trends from two weeks ago continue, with a couple of notable exceptions. Cases in Florida and Louisiana appear to be leveling off, with some decline over the last week or so in both states. With universities (potentially) opening in the next month, that trend will be tested. If cases continue to level and/or drop, this is tremendous news for this Fall. 
 
Also notable is Alabama’s continued dramatic surge of hospitalizations remains puzzling. As you’ll see in the chart below, hospitalizations are so high that it would mean nearly everyone who tested positive over the last couple of weeks ended up in the hospital. I was skeptical two weeks ago and now I find it almost impossible to believe. Again, I checked the numbers with Alabama’s health department and the totals add up, but I remain convinced that hospitalizations were inaccurately counted for weeks or months and the data is now catching up to reality. 

Covid Numbers for the Week

 

7-Day Moving Average for Southeastern States
New Cases & New Hospitalizations 

(LA & NC do not report hospitalizations)
Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
Linear Case Growth

7-Day Moving Average for Southeastern States
New Tests & Positive Tests

Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter

July 22 Covid-19 Update

Covid Numbers for the Week

 

7-Day Moving Average for Southeastern States
New Cases & New Hospitalizations 

(LA & NC do not report hospitalizations)
Southeast Covid-19 Updates. Alabama 7-Day Moving Average, New Cases and New Hospitalizations
Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
Linear Case Growth

7-Day Moving Average for Southeastern States
New Tests & Positive Tests

Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter

Allyson Bower-Willner succeeding Tiffany Wilson as chair of Medtech Women AdvanSE at Southeast Life Sciences

During the 2020 Medtech Women AdvanSE of Southeast Life Sciences (formerly Medtech Women@SEMDA) virtual event on September 8, 2020, Founder, Chair and GCMI CEO Tiffany Wilson will pass the gavel to Allyson Bower-Willner. Willner, Marketing Director for Strategic Accounts with Molynlycke Health Care, has served on the MW@S board since its inception in 2016.

“We founded Medtech Women to serve as a strong advisory network for mentoring and professional development for female professionals and innovators across the medical technology industry in the Southeast,” Wilson said. “There is a meaningful gender gap in the C Suite. We know this. At the same time we are seeing more female technologists — doctors and engineers — with their names on patents, but we are not seeing a corresponding jump in the number of women involved in medtech startups.”

“Our goal is to continue our work making the southeast a world-class region for the medical device industry,” Willner said. “Medtech Women can play an integral role in that mission by enhancing the opportunities for female inventors, entrepreneurs, and other industry professionals in the southeast.”

Since its inception, Medtech Women@SEMDA has evolved to include an advisory board of 20 medtech and life science executives, physicians and successful entrepreneurs. The group has added educational programs, webinars and is now positioned to expand its capabilities and reach in large part thanks to the merging of the Southeastern Medical Device Association (SEMDA) with SE BIO in the new combined entity Southeast Life Sciences.

“The convergence of medical technologies, including devices, with bioscience technologies including drugs, data, digital and combination products necessitates the convergence of these entities,” former SEMDA Executive Director and now Southeast Life Science Executive Director Jason Rupp said. “In order to respond to the combined needs of stakeholders in both ecosystems, the time arrived for SEBIO and SEMDA to come together under one roof.”

“We have given Medtech Women life and validated its reason for being: creation of opportunities for women in medtech and life sciences for growth, leadership and professional development,” Wilson says. “Shifting from start-up mode into growth mode and maturity is an exciting time for any organization, particularly in an ever evolving industry like medtech and the life sciences.” 

“Thanks to the chair and the board’s leadership to date, and the remarkable environment in which we all find ourselves, the impact potential for Medtech Women AdvanSE is high,” Willner said. “We encourage all members of the southeast life science ecosystem to engage with us. Registering for the 5th annual Medtech Women AdvanSE virtual conference is an excellent place to start.” 

 

Those interested in serving on a committee like programming, conference, sponsorship or other should contact Jason Rupp at jrupp@southeastlifesciences.org or (202) 438-4960

July 7 Covid Newsletter

Covid Numbers for the Week

 

7-Day Moving Average for Southeastern States
New Cases & New Hospitalizations 

(LA & NC do not report hospitalizations)
Alabama
Arkansas
Florida
Southeast Covid-19 Updates. Georgia 7 day moving average new cases and new hospitalizations.
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
Linear Case Growth

7-Day Moving Average for Southeastern States
New Tests & Positive Tests – with R-Squared Values 

Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter

June 30 Covid Newsletter

Seven-Day Moving Average – New Cases & New Tests by State

The spike continues for most of the southeast, with Florida looking really bad. In the last week, Florida’s total cases grew by 45%, from 97,000 to 141,000. The numbers there are so high, it skews all the other states, so I had to take them out of the linear growth chart for the region.

The only exception in the spikes is Virginia, which has reduced new infections significantly since their spike peaked a month ago. Below are charts for Florida and Virginia, with some commentary.

Before I get there, one major assumption on my part as I interpret this data is that testing needs to outpace cases. When testing is higher, and growing faster, than new infections, the state has a good grasp on the overall impact of the virus. It means more healthy people are getting tested and the overall percentage of positives is low. As new cases catch up to testing, it’s showing that more people are getting tested because they are sick. If the growth rate of cases is outpacing testing, then it’s getting out of control.

This assumption becomes important in causation vs. correlation. When I look at these charts, there is some obvious correlation between testing and cases, but only when there are spikes in cases. When the states had more strict guidelines in place, testing far exceeded new cases. In that case there is no correlation and certainly no causation would exist. When the cases start ramping up, which they are now, the testing ramps up equally. Are we getting more cases because there is more testing; or are we getting more testing because there are more cases? 

Covid Numbers for the Week

 

7-Day Moving Average of New Cases for Southeastern States

Alabama
Arkansas
Southeast Covid-19 Updates. Florida 7 day moving average. New cases and new tests
Florida
Southeast Covid-19 Updates. Georgia 7-Day Moving average. New cases and new tests
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
May 24 Linear Case Growth

7-Day Moving Average of New Hospitalizations for Southeastern States

Alabama
Arkansas
Florida
Georgia
Kentucky
Mississippi
South Carolina
Tennessee
Virginia

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter

June 24 Covid Newsletter

Covid Numbers for the Week

 

7-Day Moving Average of New Cases for Southeastern States

Alabama
Arkansas
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
Southeast Covid-19 Updates. Covid-19 Linear growth rate for southeast states.
May 24 Linear Case Growth

7-Day Moving Average of New Hospitalizations for Southeastern States

Alabama
Arkansas
Florida
Georgia
Kentucky
Mississippi
South Carolina
Tennessee
Virginia

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter

June 7 Covid Newsletter

Covid Numbers for the Week

 

7-Day Moving Average of New Cases for Southeastern States

Alabama
Arkansas
Southeast Covid-19 Updates. Florida new covid cases per day growth chart.
Florida
Georgia
Kentucky
Louisiana
Mississippi
North Carolina
South Carolina
Tennessee
Virginia
May 24 Linear Case Growth

Upcoming Free Content

The Future of Medical Devices: How COVID-19 and the rise of digital health has changed regulatory, clinical, and reimbursement  dynamics in the medical device industry, June 23 
PhRMA: COVID-19 Bending the Curve, May 28 – June 11
DeviceTalks Tuesday, Weekly discussions and workshops for Medtech companies who want to ensure their teams are atop of this changing world. Starting May 19
 

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-162914190-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-162914190-1'); </script>
April 6 Covid-19 Newsletter